Cardiff, United Kingdom
Cellesce Ltd, founded in 2013, is a promising player in the fields of Biotechnology and Manufacturing, headquartered in the United Kingdom. The company is carving out a niche in the development, scale-up, and manufacture of patient-derived organoids (PDOs), a cutting-edge technology with significant potential for transforming medical research and drug development.
With a vision encapsulated in their slogan, "Cellesce specialises in the development, scale up and manufacture of PDOs (patient-derived organoids)," the company leverages biochemical engineering expertise to innovate within an area poised for growth.
The company's recent capital injection, a £1.50M Seed Round secured on 01 June 2019 from Tangram Partners Limited, underscores investor confidence in their technological capabilities and market potential. Cellesce Ltd is well-positioned to capitalize on the increasing demand for biologically relevant models in research, supported by their advanced PDO technology platform.
